Press release
Skanska announces order cancellation in Massachusetts, USA, worth USD 112M, about SEK 1.2 billion
Skanska announces that Continuus Pharmaceuticals has cancelled the project to build a pharmaceutical manufacturing facility in Woburn, Massachusetts, USA. The order cancellation is worth USD 112M, about SEK 1.2 billion, which will be recorded in the US order bookings for the second quarter of 2023.
For further information please contact:
Chris Mckniff, Communications Director, Skanska USA Building, tel +1 (347) 409 2719
Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com.
Media Relations contacts
Are you a journalist looking for information about Skanska or have questions about our operations? Our Media Relations team can help with press inquiries, interviews, background information and access to relevant resources.
Jacob Birkeland
Head of Media Relations & Public Affairs
Andreas Joons
Media Relations Manager
Olof Rundgren
Media Relations Manager